CIK 0001642380
- Non-accelerated filer
- Smaller reporting company
Insight Molecular Diagnostics Inc.
Sign in to watch- Ticker
- IMDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 271041563
- Phone
- +1 949-409-7600
- Business address
- 2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
- Former names
- OncoCyte Corp, Oncocyte Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 23 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-23 | BROADWOOD PARTNERS, L.P. 10% owner | Option exercise | +0 | 17,349,945 | ||
| 2021-09-23 | BROADWOOD PARTNERS, L.P. 10% owner | Returned to the company · Warrant to Purchase Common Stock | −573,461 | 0 | ||
| 2021-09-23 | BROADWOOD PARTNERS, L.P. 10% owner | Returned to the company · Warrant to Purchase Common Stock | −0 | 0 | ||
| 2021-09-23 | BROADWOOD PARTNERS, L.P. 10% owner | Grant or award · Warrant to Purchase Common Stock | +573,461 | 573,461 | ||
| 2021-09-23 | BROADWOOD PARTNERS, L.P. 10% owner | Grant or award · Warrant to Purchase Common Stock | +0 | 573,461 | ||
| 2021-09-23 | BROADWOOD PARTNERS, L.P. 10% owner | Option exercise · Warrant to Purchase Common Stock | −573,461 | 0 | ||
| 2021-09-23 | BROADWOOD PARTNERS, L.P. 10% owner | Option exercise · Warrant to Purchase Common Stock | −0 | 0 | ||
| 2021-07-01 | ANDREWS RONALD ASBURY Chief Executive Officer | Option exercise | +65,000 | 259,046 | ||
| 2021-07-01 | ANDREWS RONALD ASBURY Chief Executive Officer | Shares withheld for taxes | −15,834 | 243,212 | ||
| 2021-07-01 | ANDREWS RONALD ASBURY Chief Executive Officer | Option exercise · Restricted Stock Units | −65,000 | 0 | ||
| 2021-06-30 | ANDREWS RONALD ASBURY Chief Executive Officer | Shares withheld for taxes | −25,873 | 194,046 | ||
| 2021-06-24 | Yu Li VP Cntrllr/Prncpl Acctng Offcr | Grant or award · Option to Purchase Common Stock | +160,000 | 160,000 | ||
| 2021-06-24 | Redmond Cavan M. Director | Grant or award · Option to Purchase Common Stock | +45,000 | 45,000 | ||
| 2021-06-24 | Redmond Cavan M. Director | Grant or award · Restricted Stock Units | +10,000 | 10,000 | ||
| 2021-06-24 | Carter Jennifer L. Director | Grant or award · Option to Purchase Common Stock | +45,000 | 45,000 | ||
| 2021-06-24 | Carter Jennifer L. Director | Grant or award · Restricted Stock Units | +10,000 | 10,000 | ||
| 2021-06-24 | Last Andrew J. Director | Grant or award · Option to Purchase Common Stock | +45,000 | 45,000 | ||
| 2021-06-24 | Last Andrew J. Director | Grant or award · Restricted Stock Units | +10,000 | 10,000 | ||
| 2021-06-24 | KINGSLEY ALFRED D Director | Grant or award · Option to Purchase Common Stock | +45,000 | 45,000 | ||
| 2021-06-24 | KINGSLEY ALFRED D Director | Grant or award · Restricted Stock Units | +10,000 | 10,000 |
Page 13 of 20 · 383 trades